Literature DB >> 24760059

Control of hypertension after roux-en-y gastric bypass among obese diabetic patients.

Everton Cazzo1, Martinho Antonio Gestic1, Murillo Pimentel Utrini1, Ricardo Rossetto Machado1, José Carlos Pareja1, Elinton Adami Chaim1.   

Abstract

CONTEXT: Hypertension is a common disorder in general practice and has a widely known association with type 2 diabetes mellitus. Low adhesion to clinical treatment may lead to poor results. Obesity surgery can bring early and relevant resolution rates of both morbidities.
OBJECTIVE: To describe hypertension evolution after Roux-en-Y gastric bypass in patients with type 2 diabetes mellitus.
METHOD: Descriptive observational study designed as a historical cohort of 90 subjects with hypertension and diabetes who underwent Roux-en-Y gastric bypass and were evaluated before and after surgery.
RESULTS: It was observed a hypertension resolution rate of 85.6% along with markedly decrease in anti-hypertensive usage. Mean resolution time was 3.2 months. Resolution was associated with homeostasis model assessment - insulin resistance, preoperative fasting insulin, anti-hypertensive usage, hypertension time, body mass index and percentage of weight loss. Resolution of hypertension was not statistically associated with diabetes remission within this sample.
CONCLUSION: Roux-en-Y gastric bypass was a safe and effective therapeutic tool to achieve hypertension resolution in patients who also had diabetes mellitus.

Entities:  

Mesh:

Year:  2014        PMID: 24760059     DOI: 10.1590/s0004-28032014000100005

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  5 in total

Review 1.  Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension.

Authors:  Thierry H Le Jemtel; William Richardson; Rohan Samson; Abhishek Jaiswal; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2017-02       Impact factor: 5.369

Review 2.  Changes in Antihypertensive Medication Following Bariatric Surgery.

Authors:  Gabriel S Tajeu; Emily Johnson; Mason Buccilla; Crystal A Gadegbeku; Shane Janick; Daniel Rubin; Rohit Soans; Vikram J Eddy; David B Sarwer
Journal:  Obes Surg       Date:  2022-01-26       Impact factor: 3.479

3.  Impact of Weight Regain on the Evolution of Non-alcoholic Fatty Liver Disease After Roux-en-Y Gastric Bypass: a 3-Year Follow-up.

Authors:  Laísa Simakawa Jimenez; Fábio Henrique Mendonça Chaim; Felipe David Mendonça Chaim; Murillo Pimentel Utrini; Martinho Antonio Gestic; Elinton Adami Chaim; Everton Cazzo
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

4.  MS4A6A genotypes are associated with the atrophy rates of Alzheimer's disease related brain structures.

Authors:  Jing Ma; Wei Zhang; Lin Tan; Hui-Fu Wang; Yu Wan; Fu-Rong Sun; Chen-Chen Tan; Jin-Tai Yu; Lan Tan
Journal:  Oncotarget       Date:  2016-09-13

5.  A survey of primary care physician referral to bariatric surgery in Manitoba: access, perceptions and barriers.

Authors:  Mostafa El-Beheiry; Ashley Vergis; Jung-Un Choi; Kathleen Clouston; Krista Hardy
Journal:  Ann Transl Med       Date:  2020-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.